IP62-02: Biomarkers of response to prostate cancer vaccine and immune checkpoint inhibition: Synergistic regulation of soluble CD137 and IL-15

IP62-02: Biomarkers of response to prostate cancer vaccine and immune checkpoint inhibition: Synergistic regulation of soluble CD137 and IL-15

Sunday, May 17, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)

146A

Abstract

Sessions

Sunday, May 17, 2026 1:00 PM to 3:00 PM

Registered attendees

Erin Mayeux

ResearcherJohns Hopkins School of Medicine

Log in

See all the content and easy-to-use features by logging in or registering!